REACH

Serial Number 97292298
606

Registration Progress

Application Filed
Mar 2, 2022
Under Examination
Jun 13, 2023
Approved for Publication
Apr 18, 2023
Published for Opposition
Apr 18, 2023
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: REACH
Previous Owner: Fulcrum Therapeutics, Inc.
Classes: 042, 044

Trademark Image

REACH

Basic Information

Serial Number
97292298
Filing Date
March 2, 2022
Published for Opposition
April 18, 2023
Abandonment Date
January 13, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 13, 2025
Classes
042 044

Rights Holder

Fulcrum Therapeutics, Inc.

03
Address
26 Landsdowne Street
Cambridge, MA 02139

Ownership History

Fulcrum Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Fulcrum Therapeutics, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Gina A. Bibby

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

33 events
Date Code Type Description Documents
Jan 13, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jan 13, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 2, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 1, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 1, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
May 1, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 10, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 9, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 13, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 7, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 19, 2023 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Dec 19, 2023 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Dec 19, 2023 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Dec 19, 2023 PETG O PETITION TO REVIVE-GRANTED Loading...
Dec 19, 2023 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Dec 18, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Dec 18, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 18, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 18, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 13, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 18, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 18, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 29, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 16, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 15, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 13, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 13, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 12, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 12, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 12, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 27, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 7, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 5, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Clinical research in the field of Facioscapulohumeral Muscular Dystrophy/Atrophy; Testing, inspection, research, or development of pharmaceutical preparations for treatment of Facioscapulohumeral Muscular Dystrophy/Atrophy; Pharmaceutical products development; Development of pharmaceutical preparations and medicines
Class 044
Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Classification

International Classes
042 044